Flagship Biosciences
PrivateLast Round
Growth Equity
Aug 31, 2022
Total Funding Raised
$656,525
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Flagship Biosciences operates in Healthcare & Life Sciences and is based in Broomfield, Colorado. Its latest recorded funding round was a Growth Equity round in August 2022.
Flagship Biosciences is a life sciences company that provides digital pathology and spatial biology services to support drug development and clinical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Imaging, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flagship Biosciences Comparables
Compare Flagship Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OracleBio | 88% | |
| Aignostics | 81% | |
| Indica Labs | 81% |
For institutional investors. Book with your work email.
Flagship Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Aug 31, 2022 | ||||
| Debt | Feb 11, 2021 | ||||
| Debt | Apr 14, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Flagship Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Research Corporation Technologies | Growth Equity |
| BroadOak Capital Partners | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 40% MoM.
- Aug 31, 2022
BroadOak Capital Partners and Research Corporation Technologies participated.
For institutional investors. Book with your work email.
Flagship Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Flagship Biosciences's valuation, stock price, and market status.
Is Flagship Biosciences a public or private company?
Flagship Biosciences is a private company.
What is the current stock price of Flagship Biosciences?
Flagship Biosciences is a private company, so its shares have no public market price. Caplight tracks Flagship Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Flagship Biosciences worth (valuation)?
Valuation information for Flagship Biosciences is not publicly available.
Can I buy Flagship Biosciences stock?
Flagship Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Flagship Biosciences's last funding round?
Flagship Biosciences's most recent funding round was Growth Equity on August 31, 2022.
Who are the main investors in Flagship Biosciences?
Key investors in Flagship Biosciences include Research Corporation Technologies, BroadOak Capital Partners.
Will Flagship Biosciences IPO soon?
No public IPO plans have been announced for Flagship Biosciences.
How can I track Flagship Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Flagship Biosciences's shares on secondary markets.